As countries around the world strive to remain on top of the management of the COVID-19 disease, which has infected more than 3.5million worldwide, Ghana has stepped up its efforts to maintain its lead of the virus.
The country is set to begin the production of Hydroxychloroquine and Azithromycin, two medicines that have proven effective for the treatment of COVID-19 patients.
The disease, which has been declared a global health risk, has no specified cure or vaccines but people diagnosed positive can be managed and treated.
The production is a collaboration between Tobinco Pharmaceutical Group of Companies and the EXIM Bank Ghana that has seen the Bank approve a $5 million facility to Entrance Pharmaceuticals and Research Centre, a member of the Tobinco.
Confirming the news on Accra-based Okay FM, Monday, Chief Executive Officer (CEO) of the Tobinco Pharmaceutical Group of Companie, Samuel Amo Tobbin said the two drugs have been identified as a possible treatment for the virus and will be produced till the pandemic is over.
Though the World Health Organization (WHO) says there’s no definitive evidence Chloroquine, and a related derivative, hydroxychloroquine can work on COVID-19 patients, Mr Tobbin stated that a global surge in demand for the drugs and the usage of same for Ghana’s treatment plan to an extent influenced the need to produce the drugs in Ghana.
“We will produce so many of the drugs and it’s not going to be done with a day or two weeks or a year because no one knows when the pandemic will cease and so we will produce till COVID-19 leaves the system or till the money gets finished.
“Since this pandemic began, the Whites have tried so many drugs and what has been seen so far as capable to curing the virus is that the Hydroxychloroquine and azithromycin. It is also because suddenly the price for Hydroxychloroquine has all of a sudden shot up in the market and that is what is being used in Ghana to treat the patients,” he added.
Speaking to Daily Graphic Chairman of the Exim Bank Credit Subcommittee, Nana Dr Appiagyei Dankawoso II, said the move has become necessary to boost local production of the items as there’s a general shortage of the drugs on the market.
Board Chairman of the Bank, Kwadwo Boateng Genfi also said “Ghana Exim was highly impressed with Tobinco’s utilisation of a previous grant extended to the group and, therefore, was ready to advance a new $5 million to help tackle the pandemic in the country,’’ during a visit by members of the Exim Bank Credit Subcommittee to the Entrance Pharmaceuticals and Research Centre.
Written and Published : By 247